Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Limestone Fund has partnered with TriStar Technology Ventures to built a new molecular diagnostics company - Diagnovus, headquartered in Nashville, Tennessee.
Subscribe to our email newsletter
At its new site, Diagnovus will develop diagnostic tests and offer information about rare forms of cancer, including pediatric cancers to physicians, payers, patients and families.
The new company will also detect, in-license, develop and commercialize diagnostic assays that have been developed at institutions around the US.
Limestone Fund principal Joe Cook said they believe Diagnovus can focus on providing better individualized information to physicians, patients and caregivers in less frequent cancers.